Bristol-Myers Squibb
BMY
BMY
1,727 hedge funds and large institutions have $74.8B invested in Bristol-Myers Squibb in 2018 Q3 according to their latest regulatory filings, with 107 funds opening new positions, 575 increasing their positions, 744 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,727
Holders Change
+38
Holders Change %
+2.25%
% of All Funds
39.55%
Holding in Top 10
42
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+7.69%
% of All Funds
0.96%
New
107
Increased
575
Reduced
744
Closed
53
Calls
$1.32B
Puts
$1.24B
Net Calls
+$82.4M
Net Calls Change
-$163M
Top Buyers
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$379M |
| 2 |
Jennison Associates
New York
|
+$253M |
| 3 |
State Street
Boston,
Massachusetts
|
+$190M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$180M |
| 5 |
BlackRock
New York
|
+$165M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$397M |
| 2 |
Barclays
London,
United Kingdom
|
-$214M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$213M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$201M |
| 5 |
JPMorgan Chase & Co
New York
|
-$193M |
